These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 31926833)

  • 1. Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors.
    Quartuccio L; Bond M; Isola M; Monti S; Felicetti M; Furini F; Murgia S; Berti A; Silvestri E; Pazzola G; Bozzolo E; Leccese P; Raffeiner B; Parisi S; Leccese I; Cianci F; Bettio S; Sainaghi P; Ianniello A; Ravagnani V; Bellando Randone S; Faggioli P; Lomater C; Stobbione P; Ferro F; Colaci M; Alfieri G; Carubbi F; Erre GL; Giollo A; Franzolini N; Ditto MC; Balduzzi S; Padoan R; Bortolotti R; Bortoluzzi A; Cariddi A; Padula A; Di Scala G; Gremese E; Conti F; D'Angelo S; Matucci Cerinic M; Dagna L; Emmi G; Salvarani C; Paolazzi G; Roccatello D; Govoni M; Schiavon F; Caporali R; De Vita S;
    J Autoimmun; 2020 Mar; 108():102397. PubMed ID: 31926833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of risk factors associated with diffuse alveolar haemorrhage in patients with ANCA-associated vasculitis and construction of a risk prediction model using line graph.
    Li X; Ma C; Xu J; Zhang M; Xiang Q; Li Y; Li W; Zhu P
    Clin Exp Rheumatol; 2024 Apr; 42(4):864-871. PubMed ID: 38634373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alveolar Hemorrhage in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Results of an International Randomized Controlled Trial (PEXIVAS).
    Fussner LA; Flores-Suárez LF; Cartin-Ceba R; Specks U; Cox PG; Jayne DRW; Merkel PA; Walsh M;
    Am J Respir Crit Care Med; 2024 May; 209(9):1141-1151. PubMed ID: 38346237
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of concurrent glomerulonephritis on outcomes of diffuse alveolar haemorrhage in antineutrophil cytoplasmic antibody-associated vasculitis.
    Cohen SP; Wodarcyk AJ; Wong A; Patterson KC; Lyons MI; Barnes A; Strickland A; Pan X; Almaani S; Meara AS; Crouser ED; Wewers MD; Fussner LA
    Clin Exp Rheumatol; 2024 Apr; 42(4):811-815. PubMed ID: 37976113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality and cardiovascular risk in vasculitis ANCA. Importance of hypertension and renal function. Experience from southern Spain.
    Martin-Gómez MA; Rodríguez Torres A; Espinosa Hernández M; Lopez Mendoza M; Sabio Sánchez JM; Martin Armada M; Martin Suarez I; Callejas Rubio JL; Castilla Castellano MM; Anglada Pintado JC; Barnosi Marín AC; Martinez Esteban MD; Castilla Guerra L; De Ramón Garrido E;
    Hipertens Riesgo Vasc; 2024; 41(1):5-16. PubMed ID: 37517951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Earliest total vascular damage index scores independently predict all-cause mortality in patients with ANCA-associated vasculitis.
    Koo G; Ha JW; Ahn SS; Song JJ; Park YB; Lee SW
    Clin Exp Rheumatol; 2024 Apr; 42(4):795-802. PubMed ID: 38179702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rare cause of diffuse alveolar haemorrhage and subconjunctival haemorrhage rescued by extracorporeal membrane oxygenation and rituximab.
    Hu Z; Feng X; Zhang B; Huang J
    BMJ Case Rep; 2022 Jun; 15(6):. PubMed ID: 35750426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic challenge of hemoptysis in a hemodialysis patient.
    Martin F; Leandro A; Giuliana V
    Eur J Intern Med; 2024 Jul; ():. PubMed ID: 39048337
    [No Abstract]   [Full Text] [Related]  

  • 9. Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis.
    Sebastiani M; Manfredi A; Vacchi C; Cassone G; Faverio P; Cavazza A; Sverzellati N; Salvarani C; Luppi F
    Clin Exp Rheumatol; 2020; 38 Suppl 124(2):221-231. PubMed ID: 32324122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.
    Walsh M; Merkel PA; Peh CA; Szpirt WM; Puéchal X; Fujimoto S; Hawley CM; Khalidi N; Floßmann O; Wald R; Girard LP; Levin A; Gregorini G; Harper L; Clark WF; Pagnoux C; Specks U; Smyth L; Tesar V; Ito-Ihara T; de Zoysa JR; Szczeklik W; Flores-Suárez LF; Carette S; Guillevin L; Pusey CD; Casian AL; Brezina B; Mazzetti A; McAlear CA; Broadhurst E; Reidlinger D; Mehta S; Ives N; Jayne DRW;
    N Engl J Med; 2020 Feb; 382(7):622-631. PubMed ID: 32053298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ANCA-associated vasculitis.
    Kitching AR; Anders HJ; Basu N; Brouwer E; Gordon J; Jayne DR; Kullman J; Lyons PA; Merkel PA; Savage COS; Specks U; Kain R
    Nat Rev Dis Primers; 2020 Aug; 6(1):71. PubMed ID: 32855422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypocomplementemia is associated with more severe renal disease and worse renal outcomes in patients with ANCA-associated vasculitis: a retrospective cohort study.
    Chalkia A; Thomas K; Giannou P; Panagiotopoulos A; Hadziyannis E; Kapota A; Gakiopoulou H; Vassilopoulos D; Petras D
    Ren Fail; 2020 Nov; 42(1):845-852. PubMed ID: 32787590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ANCA associated vasculitis.
    Hunter RW; Welsh N; Farrah TE; Gallacher PJ; Dhaun N
    BMJ; 2020 Apr; 369():m1070. PubMed ID: 32291255
    [No Abstract]   [Full Text] [Related]  

  • 14. The value of anti-neutrophil cytoplasmic antibodies (ANCA) testing for the diagnosis of ANCA-associated vasculitis, a systematic review and meta-analysis.
    Guchelaar NAD; Waling MM; Adhin AA; van Daele PLA; Schreurs MWJ; Rombach SM
    Autoimmun Rev; 2021 Jan; 20(1):102716. PubMed ID: 33197574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Therapeutic Targets in Antineutrophil Cytoplasm Antibody-Associated Vasculitis.
    Prendecki M; McAdoo SP
    Arthritis Rheumatol; 2021 Mar; 73(3):361-370. PubMed ID: 32562366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting.
    Gatto M; Saccon F; Zen M; Regola F; Fredi M; Andreoli L; Tincani A; Urban ML; Emmi G; Ceccarelli F; Conti F; Bortoluzzi A; Govoni M; Tani C; Mosca M; Ubiali T; Gerosa M; Bozzolo E; Canti V; Cardinaletti P; Gabrielli A; Tanti G; Gremese E; De Marchi G; De Vita S; Fasano S; Ciccia F; Pazzola G; Salvarani C; Negrini S; Puppo F; Di Matteo A; De Angelis R; Orsolini G; Rossini M; Faggioli P; Laria A; Piga M; Mathieu A; Scarpato S; Rossi FW; de Paulis A; Brunetta E; Ceribelli A; Selmi C; Prete M; Racanelli V; Vacca A; Bartoloni E; Gerli R; Larosa M; Iaccarino L; Doria A
    Arthritis Rheumatol; 2020 Aug; 72(8):1314-1324. PubMed ID: 32275125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEXIVAS challenges current ANCA-associated vasculitis therapy.
    Morris A; Geetha D
    Nat Rev Nephrol; 2020 Jul; 16(7):373-374. PubMed ID: 32203311
    [No Abstract]   [Full Text] [Related]  

  • 18. Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes.
    Monti S; Craven A; Klersy C; Montecucco C; Caporali R; Watts R; Merkel PA; Luqmani R;
    Rheumatology (Oxford); 2021 Feb; 60(2):617-628. PubMed ID: 32447389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for serious infections in ANCA-associated vasculitis.
    Odler B; Riedl R; Gauckler P; Shin JI; Leierer J; Merkel PA; St Clair W; Fervenza F; Geetha D; Monach P; Jayne D; Smith RM; Rosenkranz A; Specks U; Stone JH; Kronbichler A;
    Ann Rheum Dis; 2023 May; 82(5):681-687. PubMed ID: 36702528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunopathogenesis of ANCA-Associated Vasculitis.
    Kronbichler A; Lee KH; Denicolò S; Choi D; Lee H; Ahn D; Kim KH; Lee JH; Kim H; Hwang M; Jung SW; Lee C; Lee H; Sung H; Lee D; Hwang J; Kim S; Hwang I; Kim DY; Kim HJ; Cho G; Cho Y; Kim D; Choi M; Park J; Park J; Tizaoui K; Li H; Smith L; Koyanagi A; Jacob L; Gauckler P; Shin JI
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.